Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 re... ( - New PDUFA action date assigned

Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission

Date:8/25/2009

- New PDUFA action date assigned -

LAVAL, QC, Aug. 25 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has accepted Labopharm's response regarding its novel formulation of the antidepressant trazodone as complete and designated it as a Class 2 resubmission. The FDA has assigned Labopharm a new Prescription Drug User Fee Act (PDUFA) action date of February 11, 2010.

Labopharm received a complete response letter from the FDA on July 17, 2009 indicating the Company's new drug application (NDA) for its novel trazodone formulation could not be approved in its present form due to deficiencies following the FDA's inspection of the manufacturing facility of the active pharmaceutical ingredient (API) supplier, Angelini. The letter did not raise any efficacy or safety issues. Angelini submitted an action plan addressing the deficiencies to the FDA on July 24, 2009.

Labopharm continues to prepare for the commercialization of its novel antidepressant and, pending FDA approval, intends to launch in the U.S. shortly thereafter.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, spe
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis

Post Your Comments:

(Date:5/19/2013)... 2013 These molecular diagnostics market ... Spain, Japan, Italy, Germany and France:, ... laboratory practice, as well as key economic, regulatory, ... impact during the next five years. , ... technologies, test formats, detection methodologies, trends in testing ...

(Date:5/19/2013)... May 19, 2013 Americans live closer ... the newest American Veterinary Medical Association (AVMA) U.S. Pet ... dog owners consider their dog a member of the ... said as much five years earlier. , According to ... of the national income dedicated to pets has increased ...

(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...

(Date:5/19/2013)... Passages Malibu, the leading non-12 step, holistic, and ... the launch of a “Sobriety, Health, and Wellness” survey ... “We are always looking for new ways to engage ... regarding sobriety, what’s working for people, and what isn’t,” ... Passages Addiction Treatment Centers located in Malibu and ...

(Date:5/19/2013)... HealthEconomics.Com , the global leader ... unveil a new and exciting service: HE-Xpo: a media-rich, ... array of real-time communication tools to expand their digital ... , HE-Xpo is powered by OnStream Media’s ... feel of being at a physical trade show, all ...

Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3

[0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com [0] Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey [0] HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access

... Programs During the Quarter, PALO ALTO, Calif., Nov. ... announced financial results for,the quarter ended September 30, 2007. ... of 2007 was $19.4,million, compared to net income of ... in the quarter ended September 30, 2006 included $31.6,million ...

... NEW YORK, Nov. 6 Weight Watchers,International, Inc. (NYSE: ... 29, 2007. Third Quarter 2007 Results For the ... to $337.5 million, up from $284.8 million in the third ... in the third quarter,of 2007 to $0.62 versus $0.52 in ...

... looks at hospital discharge rates in Raleigh and 6 ... ... County EMS has,participated in a seven-city study on the impact of new ... Heart,Association,s new 2005 CPR guidelines, according to the study authors in a,presentation ...

... rates in Cypress Creek and ... 6 other cities, ... in a seven-city study on the impact of new CPR techniques,the results ... CPR guidelines, according to the study authors in a,presentation at the AHA,s ...

... with Cardiac Resynchronization Therapy, researchers say , TUESDAY, Nov. ... a device that synchronizes pumping in the heart,s ventricles ... The results were presented Tuesday at a late-breaking clinical ... in Orlando, Fla., and were expected to be published ...

... Institute of Allergy and Infectious Diseases (NIAID), part of ... to strengthen and expand its nationwide group of institutions ... for infectious diseases. In addition to increasing the number ... Vaccine and Treatment Evaluation Units (VTEUs) to carry out ...

Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results Weight Watchers Announces Third Quarter 2007 Results Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device Cardiac Device Won't Help Some Heart Failure Patients NIAID strengthens and expands Vaccine and Treatment Evaluation Units

(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...

(Date:5/17/2013)... 17, 2013 Sony Biotechnology Inc. ("Sony") today announced ... (SP6800). Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22. The ... commercial audio-visual technologies into new and novel functionalities for ...

(Date:5/17/2013)... TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...

Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2 Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2 TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2

[0] Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness [0] Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color [0] TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map

... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...

... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...

Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3

Praxis EMR Among First to Apply for HITECH Certification Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Xylocaine White Blood Cell Count Western Equine Encephalitis Antibody, IgM by IFA, Serum West Nile Virus RNA by RT-PCR